Searched for
EPILEPSY IN CHILDREN
Should they now be part of a long-term investing framework? 7 healthcare stocks with upside potential of up to 25%India’s healthcare market may grow steadily, but hospital chains can grow faster as formalisation continues. Healthcare is all about market...- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Indoco Remedies gets USFDA nod to sell generic epilepsy medicineIndoco Remedies has secured approval from the US health regulator for its generic Lacosamide oral solution. This medication is used to trea...
- AI tool helps researchers treat child epilepsyAustralian researchers have developed an AI tool that helps spot tiny brain malformations in children with epilepsy, often missed in scans....
- A boy kept fainting during baths. Hyderabad doctor reveals this rare disease is found in many parts of south IndiaSai Teja, a twelve-year-old from Andhra Pradesh, suffered mysterious spells after hot water baths. Doctors initially dismissed his conditio...
- UK boy gets world's first epilepsy device inserted into skull. Know in detail about neurostimulators fitted into brainA 13-year-old kid, Oran Knowlson from Somerset is the first to test a neurostimulator device for severe epilepsy. Three more Lennox-Gastaut...
- World's first epilepsy device fitted in 13 year old UK boy's skull; Here's how the device worksOran Knowlson, a 13-year-old from England with severe epilepsy, has become the first person to trial a new device implanted in his skull to...
- Epileptic seizures stopped after part of brain removed. Details of trailblazing surgery in UKIn the trailblazing surgery, the doctors of Edinburgh Children’s Hospital have removed the brain tissue that causes seizures. For the first...
- Zydus gets final US FDA nod to market generic version of Vigabatrin tabletsCadila Healthcare Ltd on Thursday said group firm Zydus has received final approval from the US health regulator to market its generic vers...
- Smoking increases the risk of bone fracture: Five things we learnt about health from research on twinsWhat has research from twins taught us about specific diseases and the human body?
- Contribution of neuro NCDs to India's disease burden more than doubled from 1990-2009According to the findings, the burden of non-communicable neurological disorders is increasing in India mainly due to the ageing of the pop...
- Avoid talking on smartphones for long duration; prolonged use can trigger epileptic seizuresLack of awareness about prolonged state of anxiety may also aggravate seizures.
- World Epilepsy Day: Condition different from seizure, not contagious, and other myths debunkedEpilepsy is one of the fourth most common neurological diseases, globally.
- Children suffering from asthma, diabetes at increased risk of developing mental health problemsChildren with physical and mental health problems experience significant decline in their quality of life.
- Planned pregnancy can help 90% epileptic women have healthy babiesNew Delhi, Nov 19 (IANS) Planned pregnancy can help 90 per cent of epileptic women deliver healthy babies, said doctors.
- Are you epileptic? Here's how your office can help youAbout 50 million people worldwide have epilepsy, making it one of the most common neurological diseases after migraine, stroke and Alzheime...
- New mechanism behind infant epilepsy discoveredClinical trials are ongoing with a drug that, if successful, will compensate for the disrupted regulation and ameliorate the disease in chi...
- FDA approves first 3D-printed drugIn a world first, the US has approved a 3D-printed drug to treat certain types of seizures in epilepsy patients.
- Ranbaxy, Aurobindo get US FDA nod for epilepsy drugPharma firm Ranbaxy on Monday said it has received US regulatory approval for Topiramate tablets, used in the treatment of epilepsy.
- Sun Pharma gets US FDA nod to market epilepsy drugSun Pharmaceuticals says it has received US FDA approval for marketing multiple strengths of the generic version of Novartis Trileptal oxca...
Load More
